Chapter

Implantable Cardioverter-Defibrillator Trials and Prevention of Sudden Cardiac Death

Bernard J. Gersh

Edited by Margaret A. Lloyd

in Mayo Clinic Cardiology

Fourth edition

Published on behalf of © Mayo Foundation for Medical Education and Research

Published in print November 2012 | ISBN: 9780199915712
Published online May 2013 | e-ISBN: 9780199322824 | DOI: http://dx.doi.org/10.1093/med/9780199915712.003.0694

Series: Mayo Clinic Scientific Press

Implantable Cardioverter-Defibrillator Trials and Prevention of Sudden Cardiac Death

Show Summary Details

Preview

Since the early 1980s, the development of implantable cardioverter-defibrillators (ICDs) has revolutionized the approach to prevention of sudden cardiac death. Multiple clinical trials have defined the indications for ICD therapy in the prevention of primary and secondary sudden cardiac death. The current understanding of risk stratification is a victory for evidence-based medicine; perhaps no other area of cardiology has been so rigorously evaluated. As such, these fact-driven clinical trials are rich fodder for the cardiology board examination.

Chapter.  4349 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.